148 related articles for article (PubMed ID: 2569987)
1. Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis.
Carder RK; Jackson D; Morris HJ; Lund RD; Zigmond MJ
Exp Neurol; 1989 Sep; 105(3):251-9. PubMed ID: 2569987
[TBL] [Abstract][Full Text] [Related]
2. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.
Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R
Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893
[TBL] [Abstract][Full Text] [Related]
3. Release of acetylcholine and its dopaminergic control in slices from striatal grafts in the ibotenic acid-lesioned rat striatum.
Wichmann T; Wictorin K; Björklund A; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):623-31. PubMed ID: 3149721
[TBL] [Abstract][Full Text] [Related]
4. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
Snyder GL; Keller RW; Zigmond MJ
J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
[TBL] [Abstract][Full Text] [Related]
5. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats.
Jackson D; Bruno JP; Stachowiak MK; Zigmond MJ
Brain Res; 1988 Aug; 457(2):267-73. PubMed ID: 3146404
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.
MacKenzie RG; Stachowiak MK; Zigmond MJ
Eur J Pharmacol; 1989 Sep; 168(1):43-52. PubMed ID: 2511032
[TBL] [Abstract][Full Text] [Related]
8. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
Sabol B; Boldry R; Farooqui T; Chang YA; Miller D; Uretsky N
Biochem Pharmacol; 1987 May; 36(10):1679-85. PubMed ID: 3109428
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
10. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage.
Stachowiak MK; Keller RW; Stricker EM; Zigmond MJ
J Neurosci; 1987 Jun; 7(6):1648-54. PubMed ID: 3110381
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone.
Lapchak PA; Araujo DM; Quirion R; Beaudet A
J Neurochem; 1991 Feb; 56(2):651-7. PubMed ID: 1899109
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine.
Jackisch R; Duschek M; Neufang B; Rensing H; Hertting G; Herman JP
J Neurochem; 1991 Jul; 57(1):267-76. PubMed ID: 2051168
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic inhibition of striatal GABA release after 6-hydroxydopamine.
Harsing LG; Zigmond MJ
Brain Res; 1996 Oct; 738(1):142-5. PubMed ID: 8949937
[TBL] [Abstract][Full Text] [Related]
15. Development of dopamine innervation and turning behavior in dopamine-depleted infant rats receiving unilateral nigral transplants.
Snyder-Keller AM; Carder RK; Lund RD
Neuroscience; 1989; 30(3):779-94. PubMed ID: 2505162
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the stereoisomers of 3PPP on dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum.
Arbilla S; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):6-13. PubMed ID: 6092969
[TBL] [Abstract][Full Text] [Related]
17. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
18. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
Moukhles H; Nieoullon A; Daszuta A
Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the electrically evoked release of [3H]acetylcholine in rat striatal slices: an experimental model for drugs that enhance dopaminergic neurotransmission.
Baud P; Arbilla S; Langer SZ
J Neurochem; 1985 Feb; 44(2):331-7. PubMed ID: 2981280
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
